Ni Ai

Xinjiang Technical Institute of Physics & Chemistry

Also affiliated with Ministry of Health of the Russian Federation, Scientific Research Institute of Healthcare Organization and Medical Management, Ministry of Health, Xinjiang University

Materials ScienceMedicinePharmacology, Toxicology and PharmaceuticsBiochemistry, Genetics and Molecular BiologyEngineering

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 1 paper. Top paper: “Phase I trial of the TNF-α inhibitor certolizumab plus chemotherapy in stage IV lung adenocarcinomas”.

Phase I trial of the TNF-α inhibitor certolizumab plus chemotherapy in stage IV lung adenocarcinomas

Nature Communications(2022)10.1038/s41467-022-33719-6

N/A

0.449DataRank · unranked

19 citations

Jia Luo, Ni Ai, Rachel Kim, Linda S. Ahn, Anup Biswas +10 more